Hesperidin Induces Apoptosis by Inhibiting Sp1 and Its Regulatory Protein in MSTO-211H Cells |
Lee, Kyung-Ae
(Department of Biochemistry, College of Medicine, Soonchunhyang University)
Lee, Sang-Han (Department of Biochemistry, College of Medicine, Soonchunhyang University) Lee, Yong-Jin (Soonchunhyung Environmental Health Center for Asbestos-Related Disease, College of Medicine, Soonchunhyang University Cheonan Hospital) Baeg, Seung-Mi (Department of Biochemistry, College of Medicine, Soonchunhyang University) Shim, Jung-Hyun (Department of Biochemistry, College of Medicine, Soonchunhyang University) |
1 | Shanafelt, T. D., Call, T. G., Zent, C. S., LaPlant, B., Bowen, D. A., Roos, M., Secreto, C. R., Ghosh, A. K., Kabat, B. F., Lee, M. J., Yang, C. S., Jelinek D. F., Erlichman, C. and Kay, N. E. (2009) Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J. Clin. Oncol. 27, 3808-3814. DOI |
2 | Takigawa, N., Kiura, K. and Kishimoto, T. (2011) Medical treatment of mesothelioma: anything new? Curr. Oncol. Rep. 13, 265-271. DOI |
3 | Tanaka, T., Makita, H., Kawabata, K., Mori, H., Kakumoto, M., Satoh, K., Hara, A., Sumida, T., Tanaka, T. and Ogawa, H. (1997) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18, 957-965. DOI ScienceOn |
4 | Tsuda, H., Ohshima, Y., Nomoto, H., Fujita, K., Matsuda, E., Iigo, M., Takasuka, N. and Moore, M. A. (2004) Cancer prevention by natural compounds. Drug Metab. Pharmacokinet. 19, 245-263. DOI |
5 | Yang, M., Tanaka, T., Hirose, Y., Deguchi, T., Mori, H. and Kawada, Y. (1997) Chemopreventive effects of diosmin and hesperidin on Nbutyl- N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int. J. Cancer 73, 719-724. DOI ScienceOn |
6 | Yeh, M. H., Kao, S. T., Hung, C. M., Liu, C. J., Lee, K. H. and Yeh, C. C. (2009) Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase- 9 gene expression in human hepatocellular carcinoma cells. Toxicol. Lett. 184, 204-210. DOI |
7 | Zucali, P. A., Ceresoli, G. L., De Vincenzo, F., Simonelli, M., Lorenzi, E., Gianoncelli, L. and Santoro, A. (2011) Advances in the biology of malignant pleural mesothelioma. Cancer Treat. Rev. 37, 543-558. DOI |
8 | Li, Y., Fang, H. and Xu, W. (2007) Recent advance in the research of flavonoids as anticancer agents. Mini. Rev. Med. Chem. 7, 663-678. DOI ScienceOn |
9 | Neergheen, V. S., Bahorun, T., Taylor, E. W., Jen, L. S. and Aruoma, O. I. (2009) Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278, 229-241. |
10 | Nielsen, S. E., Freese, R., Kleemola, P. and Mutanen, M. (2002) Flavonoids in human urine as biomarkers for intake of fruits and vegetables. Cancer Epidemiol. Biomarkers. Prev. 11, 459-466. |
11 | Park, H. J., Kim, M. J., Ha, E. and Chung, J. H. (2008) Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine 15, 147-151. DOI ScienceOn |
12 | Ren, W., Qiao, Z., Wang, H., Zhu, L. and Zhang, L. (2003) Flavonoids: promising anticancer agents. Med. Res. Rev. 23, 519-534. DOI ScienceOn |
13 | Preston, R. K., Avakian, S., Beiler, J. M., Moss, J. N. and Martin, G. J. (1953) In vivo and in vitro inhibition of hyaluronidase by organic phosphates. Exp. Med. Surg. 11, 1-8. |
14 | Raja, S., Murthy, S. C. and Mason, D. P. (2011) Malignant pleural mesothelioma. Curr. Oncol. Rep. 13, 259-264. DOI |
15 | Ramos, S. (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 52, 507-526. DOI ScienceOn |
16 | Robinson, B. W. and Lake, R. A. (2005) Advances in malignant mesothelioma. N. Engl. J. Med. 353, 1591-1603. DOI |
17 | Safe, S. and Abdelrahim, M. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer 41, 2438-2448. DOI |
18 | Sankpal, U. T., Goodison, S., Abdelrahim, M. and Basha, R. (2011) Targeting Sp1 transcription factors in prostate cancer therapy. Med. Chem. 7, 518-525. DOI |
19 | Kamaraj, S., Anandakumar, P., Jagan, S., Ramakrishnan, G. and Devaki, T. (2011) Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice. Fundam. Clin. Pharmacol. 25, 91-98. DOI |
20 | Kanai, M., Imaizumi, A., Otsuka, Y., Sasaki, H., Hashiguchi, M., Tsujiko, K., Matsumoto, S., Ishiguro, H. and Chiba, T. (2011) Doseescalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother. Pharmacol. 69, 65-70. |
21 | Knekt, P., Kumpulainen, J., Jarvinen, R., Rissanen, H., Heliovaara, M., Reunanen, A., Hakulinen, T. and Aromaa, A. (2002) Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76, 560-568. |
22 | Lee, Y. R., Jung, J. H. and Kim, H. S. (2011) Hesperidin partially restores impaired immune and nutritional function in irradiated mice. J. Med. Food 14, 475-482. DOI |
23 | Kong, L. M., Liao, C. G., Fei, F., Guo, X., Xing, J. L. and Chen, Z. N. (2010) Transcription factor Sp1 regulates expression of cancerassociated molecule CD147 in human lung cancer. Cancer Sci. 101, 1463-1470. DOI |
24 | la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N. and Cameron, D. W. (2010) Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin. Pharmacokinet. 49, 449-454. DOI |
25 | Lee, K. H., Yeh, M. H., Kao, S. T., Hung, C. M., Liu, C. J., Huang, Y. Y. and Yeh, C. C. (2010) The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells. Toxicol. Lett. 194, 42-49. DOI |
26 | Li, L. and Davie, J. R. (2010) The role of Sp1 and Sp3 in normal and cancer cell biology. Ann. Anat. 192, 275-283. DOI |
27 | Davie, J. R., He, S., Li, L., Sekhavat, A., Espino, P., Drobic, B., Dunn, K. L., Sun, J. M., Chen, H. Y., Yu, J., Pritchard, S. and Wang, X. (2008) Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases. Adv. Enzyme Regul. 48, 189-208. DOI |
28 | Dimmock, J. R., Elias, D. W., Beazely, M. A. and Kandepu, N. M. (1999) Bioactivities of chalcones. Curr. Med. Chem. 6, 1125-1149. |
29 | Fresco, P., Borges, F., Diniz, C. and Marques, M. P. (2006) New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747-766. DOI ScienceOn |
30 | Fresco, P., Borges, F., Marques, M. P. and Diniz, C. (2010) The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr. Pharm. Des. 16, 114-134. DOI |
31 | Garg, A., Garg, S., Zaneveld, L. J. and Singla, A. K. (2001) Chemistry and pharmacology of the Citrus biofl avonoid hesperidin. Phytother. Res. 15, 655-669. DOI ScienceOn |
32 | Ghorbani, A., Nazari, M., Jeddi-Tehrani, M. and Zand, H. (2012) The citrus flavonoid hesperidin induces p53 and inhibits NF- activation in order to trigger apoptosis in NALM-6 cells: involvement of PPAR-dependent mechanism. Eur. J. Nutr. 51, 39-46. |
33 | Horvathova, K., Vachalkova, A. and Novotny, L. (2001) Flavonoids as chemoprotective agents in civilization diseases. Neoplasma 48, 435-441. |
34 | Howells, L. M., Britton, R. G., Mazzoletti, M., Greaves, P., Broggini, M., Brown, K., Steward, W. P., Gescher, A. J. and Sale, S. (2010) Preclinical colorectal cancer chemopreventive effi cacy and p53-modulating activity of 3',4',5'-trimethoxyfl avonol, a quercetin analogue. Cancer Prev. Res (Phila). 3, 929-939. DOI |
35 | Justesen, U., Knuthsen, P. and Leth, T. (1998) Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J. Chromatogr. A 799, 101-110. DOI ScienceOn |
36 | Choi, E. J. (2007) Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutr. Cancer 59, 115-119. DOI |
37 | Akiyama, S., Katsumata, S., Suzuki, K., Ishimi, Y., Wu, J. and Uehara, M. (2010) Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 46, 87-92. |
38 | Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A. and Rouseff, R. L. (1996) Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 60, 34-40. DOI ScienceOn |
39 | Carbone, M., Kratzke, R. A. and Testa, J. R. (2002) The pathogenesis of mesothelioma. Semin. Oncol. 29, 2-17. DOI |
40 | Chuang, J. Y., Wu, C. H., Lai, M. D., Chang, W. C. and Hung, J. J. (2009) Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int. J. Cancer 125, 2066-2076. DOI |